نتائج البحث

New Transferrin Receptor-Targeted Peptide-Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity.

• Authors : Yu J; Hebei Province Key Laboratory of Research and Development of Traditional Chinese Medicine, Institute of Chinese Mateia Medica, Chengde Medical University, Chengde 067000, China.; Mao X

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemical synthesis

• Source: Molecules (Basel, Switzerland) [Molecules] 2024 Apr 12; Vol. 29 (8). Date of Electronic Publication: 2024 Apr 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy.

• Authors : Sevieri M; Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan, 20157, Italy.; Andreata F

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology; Humans

• Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Apr 15; Vol. 22 (1), pp. 184. Date of Electronic Publication: 2024 Apr 15.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

تفاصيل العنوان

Physicochemical characterization and potential cancer therapy applications of hydrogel beads loaded with doxorubicin and GaOOH nanoparticles.

• Authors : Żmuda, Aleksandra¹; Kamińska, Weronika¹; Bartel, Marta¹

• Source: Scientific Reports. 9/6/2024, Vol. 14 Issue 1, p1-14. 14p.

تفاصيل العنوان

Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.

• Authors : Wu YW; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.; Lee DY

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Extracellular Vesicles* ; Nanoparticles*

• Source: Platelets [Platelets] 2023 Dec; Vol. 34 (1), pp. 2237134.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9208117 Publication Model: Print Cited Medium: Internet ISSN: 1369-1635

تفاصيل العنوان

In Vitro and In Vivo Imaging-Based Evaluation of Doxorubicin Anticancer Treatment in Combination with the Herbal Medicine Black Cohosh.

• Authors : Płoska A; Department of Medical Laboratory Diagnostics-Fahrenheit Biobank BBMRI.Pl, Medical University of Gdansk, 80-211 Gdansk, Poland.; Beckman Institute for Advanced Science and Technology, Urbana, IL 61801, USA.

Subjects: Cimicifuga* ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/diagnostic imaging ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy

• Source: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 15; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 15.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Targeted CRISPR activation and knockout screenings identify novel doxorubicin transporters.

• Authors : Li Y; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.; Tan M

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Neoplasms*/Neoplasms*/Neoplasms*/genetics; Humans

• Source: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2023 Dec; Vol. 46 (6), pp. 1807-1820. Date of Electronic Publication: 2023 Jul 31.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Doxorubicin and folic acid-loaded zinc oxide nanoparticles-based combined anti-tumor and anti-inflammatory approach for enhanced anti-cancer therapy.

• Authors : Gomaa S; Zoology department, Faculty of Science, Tanta University, Tanta, 31527, Egypt. .; Nassef M

Subjects: Zinc Oxide*/Zinc Oxide*/Zinc Oxide*/therapeutic use ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

• Source: BMC cancer [BMC Cancer] 2024 Jan 04; Vol. 24 (1), pp. 34. Date of Electronic Publication: 2024 Jan 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity.

• Authors : Zhang T; Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Ministry of Education, Yantai University, Yantai, China.; Li N

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/pathology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

• Source: Drug delivery [Drug Deliv] 2023 Dec; Vol. 30 (1), pp. 2189118.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464

تفاصيل العنوان

A Review on the Neurotoxic Effects of Doxorubicin.

• Authors : Kamińska K; Chair and Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland. .; Cudnoch-Jędrzejewska A

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/toxicity ; Neoplasms*/Neoplasms*/Neoplasms*/chemically induced ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

• Source: Neurotoxicity research [Neurotox Res] 2023 Oct; Vol. 41 (5), pp. 383-397. Date of Electronic Publication: 2023 Jun 23.Publisher: Springer Country of Publication: United States NLM ID: 100929017 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Supramolecular Chiral Binding Affinity-Achieved Efficient Synergistic Cancer Therapy.

• Authors : Zhou J; School of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou, Jiangsu, 225002, P. R. China.; Gu J

Subjects: Doxorubicin*/Doxorubicin*/Doxorubicin*/pharmacology ; Doxorubicin*/Doxorubicin*/Doxorubicin*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

• Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Apr; Vol. 11 (16), pp. e2308493. Date of Electronic Publication: 2024 Feb 21.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

تفاصيل العنوان